FDA Accepts Filing of the Medicines Company’s New Drug Application for Intravenous Antibiotic Oritavancin With Priority Review

[Marketwired] – The Medicines Company today announced that the U.S. Food and Drug Administration has accepted the filing of a new drug application for oritavancin, an investigational intravenous antibiotic, with priority … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view